News - Janssen-Cilag, Novartis

Filter

Current filters:

Janssen-CilagNovartis

Popular Filters

EU Commission sends antitrust complaint to Johnson & Johnson and Novartis

01-02-2013

The European Commission has informed US health care giant Johnson & Johnson (NYSE: JNJ) and Swiss drug…

DuragesicEuropefentanylGenericsJanssen-CilagJohnson & JohnsonLegalMarkets & MarketingNeurologicalNovartisPatentsPharmaceuticalSandoz

Positive NICE news for Gilenya for MS and Incivo for hep C

16-03-2012

There was good news from the UK drugs watchdog the Institute for Health and Clinical Excellence (NICE)…

Anti-viralsEuropeGilenyaIncivoJanssen-CilagJohnson & JohnsonNeurologicalNovartisPharmaceuticalPricingRegulation

EU approval for Janssen-Cilag’s Zytiga in prostate cancer and Novartis’ Votubia for SEGA

08-09-2011

Belgium-based Janssen-Cilag International, a subsidiary of US health care giant Johnson & Johnson (NYSE:…

AfinitorEuropeJanssen-CilagJohnson & JohnsonNovartisOncologyPharmaceuticalRegulationVotubiaZytiga

Back to top